Treatment of epilepsy in patients with Alzheimer's disease
- PMID: 27687685
- DOI: 10.1080/14737175.2017.1243469
Treatment of epilepsy in patients with Alzheimer's disease
Abstract
Epilepsy is significantly more frequent in AD patients than in age-matched controls, even though the true extent of the phenomenon is not clear yet. Areas covered: In this review, we describe in detail the available data on the pharmacological treatment of epilepsy in patients with AD. We also briefly describe general principles of AEDs use in elderly, as well as the potential cognitive profile of AEDs and safety of concomitant psychotropic drugs in patients with epilepsy and AD. Expert commentary: As some preclinical data suggest a role of epileptiform discharges in cognitive decline in AD, a prompt diagnosis and treatment of seizures in these patients should be pursued. The few data on the use of AEDs in AD patients suggest that newer AEDs (in particular lamotrigine and levetiracetam) might be good choices. Experimental data even support a potential role of some AEDs in modifying the disease course of AD.
Keywords: Alzheimer’s disease; EEG; antiepileptic drugs; complex partial seizures; dementia; elderly patients; epilepsy; focal epilepsy; generalized epilepsy; pharmacokinetics.
Similar articles
-
Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease.Expert Opin Pharmacother. 2018 Aug;19(11):1201-1209. doi: 10.1080/14656566.2018.1496237. Epub 2018 Jul 14. Expert Opin Pharmacother. 2018. PMID: 30009650 Review.
-
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease.Epilepsy Behav. 2010 Apr;17(4):461-6. doi: 10.1016/j.yebeh.2010.01.015. Epub 2010 Feb 25. Epilepsy Behav. 2010. PMID: 20188634 Clinical Trial.
-
From here to epilepsy: the risk of seizure in patients with Alzheimer's disease.Epileptic Disord. 2016 Mar;18(1):1-12. doi: 10.1684/epd.2016.0808. Epileptic Disord. 2016. PMID: 26907471 Review.
-
Diagnosing epileptic seizures in patients with Alzheimer's disease and deciding on the appropriate treatment plan.Expert Rev Neurother. 2024 Apr;24(4):361-370. doi: 10.1080/14737175.2024.2325038. Epub 2024 Mar 1. Expert Rev Neurother. 2024. PMID: 38426448 Review.
-
Levetiracetam: preliminary efficacy in generalized seizures.Epileptic Disord. 2003 May;5 Suppl 1:S39-44. Epileptic Disord. 2003. PMID: 12915340 Review.
Cited by
-
Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies.Curr Neuropharmacol. 2022;20(11):2029-2033. doi: 10.2174/1570159X20666220507020635. Curr Neuropharmacol. 2022. PMID: 35524669 Free PMC article.
-
Antiseizure Medications in Alzheimer's Disease from Preclinical to Clinical Evidence.Int J Mol Sci. 2023 Aug 10;24(16):12639. doi: 10.3390/ijms241612639. Int J Mol Sci. 2023. PMID: 37628821 Free PMC article. Review.
-
Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease.Epilepsia. 2022 Oct;63(10):2703-2715. doi: 10.1111/epi.17355. Epub 2022 Aug 2. Epilepsia. 2022. PMID: 35775150 Free PMC article.
-
Alzheimer's disease and epilepsy: shared neuropathology guides current and future treatment strategies.Front Neurol. 2023 Oct 23;14:1241339. doi: 10.3389/fneur.2023.1241339. eCollection 2023. Front Neurol. 2023. PMID: 37936917 Free PMC article. Review.
-
Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.Int J Mol Sci. 2022 Apr 13;23(8):4307. doi: 10.3390/ijms23084307. Int J Mol Sci. 2022. PMID: 35457126 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials